Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2026)

Amneal Pharmaceuticals' Tax Rate history runs 10 years deep, the most recent figure standing at 2.71% for Q1 2026.

• On a quarterly basis, Tax Rate fell 3161.0% year-over-year to 2.71% in Q1 2026; TTM through Mar 2026 was 0.32%, a 4378.0% decrease from a year earlier, with the FY2025 full-year figure at 8.1%, up 4239.0% from the prior year.
• Tax Rate declined to 2.71% in Q1 2026 per AMRX's latest filing, from 10.25% in the prior quarter.
• Across five years, Tax Rate topped out at 447.16% in Q3 2025 and bottomed at 35.4% in Q4 2024.
• The 5-year median for Tax Rate is 13.99% (2024), against an average of 47.54%.
• Across the five-year window, Tax Rate plunged 21868 bps in 2023 and jumped 42339 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 24.01% in 2022, then plunged by 149 bps to 11.84% in 2023, then tumbled by 199 bps to 35.4% in 2024, then soared by 129 bps to 10.25% in 2025, then tumbled by 74 bps to 2.71% in 2026.
• Per Business Quant, the three latest AMRX Tax Rate figures stand at 2.71% (Q1 2026), 10.25% (Q4 2025), and 447.16% (Q3 2025).